RANI THERAPEUTICS HOLDINGS, INC. Debt Securities, Available-for-sale, Amortized Cost
RANI THERAPEUTICS HOLDINGS, INC. (RANI) had Debt Securities, Available-for-sale, Amortized Cost of $51.23 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-13
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $51.23M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $43.19M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $48.53M.
- 2025-03-31: Debt Securities, Available-for-sale, Amortized Cost $14.41M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $51.23M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $43.19M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $48.53M 10-Q · filed 2026-08-13 |
| 2025-03-31 | $14.41M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $25.77M 10-K · filed 2026-03-26 |
| 2024-09-30 | $28.71M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $30.18M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $39.06M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $46.54M 10-K · filed 2025-03-31 |
| 2023-09-30 | $60.12M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $74.34M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $83.78M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $97.44M 10-K · filed 2024-03-20 |
| 2022-09-30 | $94.86M 10-Q · filed 2022-11-10 |